These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 37727457)

  • 21. The newly proposed plasma-glycosylated hemoglobin A1c/High-Density lipoprotein cholesterol ratio serves as a simple and practical indicator for screening metabolic associated fatty liver disease: an observational study based on a physical examination population.
    He S; Lu S; Yu C; Kuang M; Qiu J; Sheng G; Zou Y
    BMC Gastroenterol; 2024 Aug; 24(1):274. PubMed ID: 39160462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum level of free thyroxine is an independent risk factor for non-alcoholic fatty liver disease in euthyroid people.
    Shao C; Cheng Q; Zhang S; Xiang X; Xu Y
    Ann Palliat Med; 2022 Feb; 11(2):655-662. PubMed ID: 35249343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the longitudinal association between the GGT/HDL-C ratio and NAFLD: a cohort study in a non-obese Chinese population.
    Xie Q; Lu S; Kuang M; He S; Yu C; Hu C; Zou Y
    BMC Gastroenterol; 2022 Dec; 22(1):500. PubMed ID: 36471271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender-specific association between non-alcoholic fatty liver disease and type 2 diabetes mellitus among a middle-aged and elderly Chinese population: An observational study.
    Ni L; Yu D; Wu T; Jin F
    Medicine (Baltimore); 2021 Feb; 100(6):e24743. PubMed ID: 33578624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
    Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
    Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease.
    Zelber-Sagi S; Salomone F; Yeshua H; Lotan R; Webb M; Halpern Z; Santo E; Oren R; Shibolet O
    Liver Int; 2014 Jul; 34(6):e128-35. PubMed ID: 24118857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of serum alanine aminotransferase and γ-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease.
    Oh HJ; Kim TH; Sohn YW; Kim YS; Oh YR; Cho EY; Shim SY; Shin SR; Han AL; Yoon SJ; Kim HC
    Korean J Hepatol; 2011 Mar; 17(1):27-36. PubMed ID: 21494075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between the ratio of gamma-glutamyltransferase to high-density lipoprotein cholesterol and the risk of diabetes mellitus using publicly available data: a secondary analysis based on a longitudinal study in Japan.
    Zhao Y; Xin X; Luo XP
    Lipids Health Dis; 2023 Jan; 22(1):7. PubMed ID: 36650520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The nonlinear correlation between alanine aminotransferase to high-density lipoprotein cholesterol ratio and the risk of diabetes: a historical Japanese cohort study.
    Cao C; Hu H; Han Y; Yuan S; Zheng X; Zhang X; Zan Y; Wang Y; He Y
    BMC Endocr Disord; 2023 May; 23(1):124. PubMed ID: 37248447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gamma-glutamyl transferase to high-density lipoprotein cholesterol ratio has a non-linear association with non-alcoholic fatty liver disease: A secondary prospective cohort study in non-obese Chinese adults.
    Li Q; Han Y; Hu H; Zhuge Y
    Front Med (Lausanne); 2022; 9():995749. PubMed ID: 36465946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and Predictors of Nonalcoholic Fatty Liver Disease in Family Members of Patients With Nonalcoholic Fatty Liver Disease.
    Anand A; Singh AA; Elhence A; Vaishnav M; Biswas S; Gunjan D; Gamanagatti SR; Nayak B; Kumar R; Shalimar
    J Clin Exp Hepatol; 2022; 12(2):362-371. PubMed ID: 35535086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baseline and change in serum lipid and uric acid level over time and incident of nonalcoholic fatty liver disease (NAFLD) in Chinese adults.
    Huang Y; Jin T; Ni W; Zhou Y; Zhang R; Li D; Wan Y; Shi Y; Hu X; Zhong Y
    Sci Rep; 2024 Aug; 14(1):18547. PubMed ID: 39122810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical spectrum transition and prediction model of nonalcoholic fatty liver disease in children with obesity.
    Zhou X; Lin X; Chen J; Pu J; Wu W; Wu Z; Lin H; Huang K; Zhang L; Dai Y; Ni Y; Dong G; Fu J
    Front Endocrinol (Lausanne); 2022; 13():986841. PubMed ID: 36120457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between ratio of γ-glutamyl transpeptidase to high-density lipoprotein cholesterol and prevalence of nonalcoholic fatty liver disease and metabolic syndrome: a cross-sectional study.
    Feng G; Feng L; Zhao Y
    Ann Transl Med; 2020 May; 8(10):634. PubMed ID: 32566571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of non-alcoholic fatty liver disease in obese children.
    Sartorio A; Del Col A; Agosti F; Mazzilli G; Bellentani S; Tiribelli C; Bedogni G
    Eur J Clin Nutr; 2007 Jul; 61(7):877-83. PubMed ID: 17151586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between serum uric acid-to-creatinine ratio and non-alcoholic fatty liver disease: a cross-sectional study in Chinese non-obese people with a normal range of low-density lipoprotein cholesterol.
    Wang X; Han Y; Liu Y; Hu H
    BMC Gastroenterol; 2022 Sep; 22(1):419. PubMed ID: 36104672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low HDL-cholesterol levels predict hepatocellular carcinoma development in individuals with liver fibrosis.
    Crudele L; De Matteis C; Piccinin E; Gadaleta RM; Cariello M; Di Buduo E; Piazzolla G; Suppressa P; Berardi E; Sabbà C; Moschetta A
    JHEP Rep; 2023 Jan; 5(1):100627. PubMed ID: 36561127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender-specific differences in clinical and metabolic variables associated with NAFLD in a Mexican pediatric population.
    Villanueva-Ortega E; Garcés-Hernández MJ; Herrera-Rosas A; López-Alvarenga JC; Laresgoiti-Servitje E; Escobedo G; Queipo G; Cuevas-Covarrubias S; Garibay-Nieto GN
    Ann Hepatol; 2019; 18(5):693-700. PubMed ID: 31151875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Light alcohol consumption plays a protective role against non-alcoholic fatty liver disease in Japanese men with metabolic syndrome.
    Sogabe M; Okahisa T; Taniguchi T; Tomonari T; Tanaka T; Tanaka H; Nakasono M; Takayama T
    Liver Int; 2015 Jun; 35(6):1707-14. PubMed ID: 25438866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
    Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
    World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.